Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease (Q57967107)

4

0 references

author name string

Sophie Laurent

1

0 references

Mohammad Reza Ejtehadi

2

0 references

Meisam Rezaei

Protein folding and misfolding

3

0 references

publication date

2012

0 references

published in

RSC Advances

0 references

volume

2

0 references

page(s)

5008

0 references

issue

12

0 references

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

The neurobiology of zinc in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Neuroscience: Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Prevalence of dementia in the United States: the aging, demographics, and memory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Alzheimer Disease in the US Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Disease-modifying therapies for Alzheimer disease: challenges to early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Tracking Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Neurodegenerative disease: amyloid pores from pathogenic mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Alzheimer's disease and the amyloid cascade hypothesis: ten years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Beta-amyloid precursor protein cleavage by a membrane-bound protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Presenilin function and gamma-secretase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Allosteric modulation of PS1/gamma-secretase conformation correlates with amyloid beta(42/40) ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Non-steroidal anti-inflammatory drugs may modulate the protease activity of Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

A beta oligomers - a decade of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Aβ peptide fibrillar architectures controlled by conformational constraints of the monomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Purification of recombinantly expressed and cytotoxic human amyloid-beta peptide 1–42

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Anesthesia, calcium homeostasis and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Solution structure of amyloid beta-peptide (25-35) in different media

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Metal complexes as artificial proteases: toward catalytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

3D structure of Alzheimer's amyloid-beta(1-42) fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Modeling the Alzheimer Abeta17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Laminin affects polymerization, depolymerization and neurotoxicity of Abeta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Iron deposits in multiple sclerosis and Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Matrix metalloproteinase 3 haplotypes and plasma amyloid beta levels: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Role of the Blood-Brain Barrier in the Pathogenesis of Alzheimers Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor subunit 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Brain-derived neurotrophic factor increases activity of NR2B-containing N-methyl-D-aspartate receptors in excised patches from hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Role of axonal transport in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Age-dependent axonal degeneration in an Alzheimer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Beta-amyloid peptides induces neuronal apoptosis via a mechanism independent of unfolded protein responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Abeta inhibits the proteasome and enhances amyloid and tau accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Tau is essential to beta -amyloid-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Impairment of the ubiquitin-proteasome system by protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Ubiquitin in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

100 years and counting: prospects for defeating Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Active and passive immunotherapy for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Controlling amyloid beta-peptide fibril formation with protease-stable ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Inhibitors of fibril formation and cytotoxicity of beta-amyloid peptide composed of KLVFF recognition element and flexible hydrophilic disrupting element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Psychometric properties of the Folstein Mini-Mental State Examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Disease-modifying trials in Alzheimer's disease: a European task force consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Alzheimer's disease: strategies for disease modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

CSF biomarker levels in early and late onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Isoprostanes: markers and mediators of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Effect of nanoparticles on protein folding and fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Photothermal ablation of amyloid aggregates by gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Anisotropic assembly of Ag nanoprisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Divalent metal nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Dipolar structures in colloidal dispersions of PbSe and CdSe quantum dots.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Nanomaterials at work in biomedical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Protein-nanoparticle interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Molecular biomimetics: nanotechnology through biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Nucleation of protein fibrillation by nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

TiO2 nanoparticles promote beta-amyloid fibrillation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Fullerene inhibits beta-amyloid peptide aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Inhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Biosensing with plasmonic nanosensors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Adsorption of beta-hairpin peptides on the surface of water: a neutron reflection study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Medium-dependent self-assembly of an amphiphilic peptide: direct observation of peptide phase domains at the air-water interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Inhibition of the formation of amyloid β-protein fibrils using biocompatible nanogels as artificial chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-L-cysteine capped quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Human serum albumin inhibits Abeta fibrillization through a "monomer-competitor" mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Molecular dynamics with coupling to an external bath

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Copper, iron and zinc in Alzheimer's disease senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder--a postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Zinc in postmortem body tissues and fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Redox modulation of Ca2+ signaling in human endothelial and smooth muscle cells in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F

Brain cholinergic impairment in liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2RA01374F